Tavo gydytojas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 24,326 | 45,425 | 34,424 | 39,655 | 52,580 | 53,183 | 61,170 | 87,420 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 804 | 882 | 2,809 | 843 | 1,952 | 2,443 | 2,273 | 2,675 |
| Equity | 3,731 | 4,613 | 7,422 | 8,265 | 10,217 | 12,660 | 14,933 | 17,608 |
| Liabilities | 42,541 | 31,353 | 21,511 | 7,422 | 7,084 | 690 | 11,305 | 16,870 |
| Non-current assets | 37,185 | 27,574 | 20,972 | 10,019 | 3,777 | 1,390 | 9,394 | 12,364 |
| Current assets | 10,793 | 9,342 | 7,952 | 4,777 | 12,564 | 11,111 | 15,990 | 20,994 |
| Total assets | 47,978 | 36,916 | 28,924 | 14,796 | 16,341 | 12,501 | 25,384 | 33,358 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,479 | 2,495 | 5,273 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +201.1% | +86.7% | -24.2% | +15.2% | +32.6% | +1.1% | +15.0% | +42.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.7% | 2.4% | 9.7% | 5.7% | 11.9% | 19.5% | 9.0% | 8.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 21.5% | 19.1% | 37.8% | 10.2% | 19.1% | 19.3% | 15.2% | 15.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.3% | 1.9% | 8.2% | 2.1% | 3.7% | 4.6% | 3.7% | 3.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 11.4 | 6.8 | 2.9 | 0.9 | 0.7 | 0.1 | 0.8 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,692 | 22,713 | 17,212 | 19,828 | 26,290 | 23,637 | 23,679 | 29,140 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tavo gydytojas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-16 | 2025-09-24 | 12.31 |
| 2025-08-31 | 2025-08-31 | 12.31 |
| 2025-08-25 | 2025-08-27 | 12.31 |
| 2025-07-24 | 2025-07-30 | 5.52 |
| 2025-07-16 | 2025-07-23 | 5.50 |
| 2025-06-18 | 2025-07-01 | 5.50 |
Tavo gydytojas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tavo gydytojas, UAB (company code 304466863) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €87.4K, up 42.9% year on year and 64.4% over two years. Net profit for 2025 was €2.7K, slightly above the €2.3K reported in 2024 and €2.4K in 2023, while the profit margin declined from 4.6% in 2023 to 3.7% in 2024 and 3.1% in 2025. The business therefore expanded its turnover faster than profitability. At the balance-sheet level, total assets increased from €12.5K in 2023 to €25.4K in 2024 and €33.4K in 2025, supported by a rise in long-term assets to €12.4K and short-term assets to €21.0K. Equity strengthened to €17.6K in 2025, while liabilities increased to €16.9K. Key ratios for 2025 show ROE of 15.2%, ROA of 8.0%, debt-to-equity of 0.96, and asset turnover of 2.62x. Revenue per employee was €29.1K, indicating a modest operating scale.